"address the defect" is a correct and usable part of a sentence in written English.
It means to take action in order to fix or correct a flaw or issue. Example: In order to ensure customer satisfaction, the company needs to address the defect in the product design.
Boston Scientific says it identified the cause of the problem, a design flaw, and has already changed how it makes its stents to address the defect that leads to problems in some cases.
While Boston Scientific says it has identified the design flaw that was the cause of the problem, and changed how it makes the stents to address the defect, the company said yesterday that it had identified problems in its method of inspecting the stents at its plant in Galway, Ireland, during the first three days of a new inspection process.
In Section 2, we review the SVC and the related resource allocation algorithms, and then address the defects in the previous algorithms.
Treatments that delay or reduce cell loss will provide time to patients, while therapies that address the defects can be developed and applied to the remaining, non-degenerating cell populations.
"The matter is not closed until Toyota has effectively addressed the defect by providing a suitable vehicle-based solution," said the regulatory agency.
In addition, we carried out electron spin resonance experiments addressing the defect creation during annealing.
The series of PL studies indicate that the GaN regrowth and the NH3 annealing condition before the QD/QW-active region growth could potentially lead to solutions for addressing the defect generated from the SiN x deposition on GaN templates.
Those who think that Europe simply must address the founding defect of the euro now and move towards a European economic government must deal with these two awkward facts.
And, while this drug targets a very specific form of cystic fibrosis that occurs in only four per cent of patients, the fact that similar drugs — which are also intended to address the basic defect in the faulty CFTR protein and which have shown promising results in initial laboratory trials — are being developed by Vertex and other companies seems to signal a new treatment paradigm.
These results highlight the importance of finding a surgical alternative that is able to correct and address the articular defect without leading to iatrogenic hazard.
Classical insulin secretagogues (sulfonylureas and glynides) exclusively act on the beta-cell and stimulate insulin secretion, but do not address the secretion defect of the alpha cells.
